Arkolith/Insider Trading/ARQT/Form 4

Krishnamohan Neha

DirectorArcutis Biotherapeutics, Inc. (ARQT) · full profile →Form 4 · filed Nov 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$940K
Net Open-Market Flow
-$940K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 13, 2025Sell(S)1K$23.37$29K22K
Nov 13, 2025Sell(S)39K$23.19$911K23K
Nov 13, 2025Option exercise(M)12K$7.51$92K63K
Nov 13, 2025Option exercise(M)27K$8.63$233K50K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 13, 2025Option exercise(M)27K—$00
Nov 13, 2025Option exercise(M)12K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001866171-25-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML